Amends TCA Title 56; Title 63; Title 68 and Title 71.

Tennessee HB0070 mandates that health insurance carriers provide coverage and reimbursement for biomarker testing for preeclampsia under TennCare health benefit plans renewed or issued on or after July 1, 2025. The bill affects pregnant women who may be screened for preeclampsia through biomarker testing ordered by their attending physician, ensuring that the tests are conducted according to recognized clinical guidelines. Key provisions include the definition of biomarker tests, the requirement for tests to be ordered by a healthcare provider, and the authorization for the division of TennCare to establish rules and seek federal waivers for Medicaid coverage.